SEC Form 4 · accession 0000856982-18-000090
MERIT MEDICAL SYSTEMS INC · MMSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nolan E. Karras
Director
Period of report
Nov 29, 2018
Accepted (ET)
Dec 3, 2018 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000856982
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par ValueF1 | Nov 29, 2018 | M | 3,000 | $9.95 | A | 4,000 | D | |
| Common Stock, No Par ValueF2,F1 | Nov 29, 2018 | S | 2,000 | $61.275 | D | 2,000 | D | |
| Common Stock, No Par Value | holding | — | — | — | 2,000 | I | Trustee for Revocable Trust | |
| Common Stock, No Par Value | holding | — | — | — | 4,000 | I | By IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock options (right to buy)F3 | $9.95 | Nov 29, 2018 | M | 3,000 | D | May 22, 2014 | May 22, 2020 | Common Stock | 3,000 | 22,000 | D |
| Non-qualified stock options (right to buy)F4 | $13.99 | holding | — | — | — | Jun 11, 2015 | Jun 11, 2021 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F5 | $20.27 | holding | — | — | — | May 22, 2016 | May 22, 2022 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F6 | $18.80 | holding | — | — | — | May 26, 2017 | May 26, 2023 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F7 | $34.40 | holding | — | — | — | May 24, 2018 | May 24, 2024 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F8 | $50.50 | holding | — | — | — | Jun 7, 2019 | Jun 7, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Shares held jointly by the reporting person and his spouse.
- F2The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.25 to $61.30, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3Becomes exercisable in equal annual installments of 20% commencing 5/22/2014.
- F4Becomes exercisable in equal annual installments of 20% commencing 6/11/2015.
- F5Becomes exercisable in equal annual installments of 20% commencing 5/22/2016.
- F6Becomes exercisable in equal annual installments of 20% commencing 5/26/2017.
- F7Becomes exercisable in equal annual installments of 20% commencing 5/24/2018.
- F8Becomes exercisable in equal annual installments of 20% commencing 6/07/2019.